USANA Health Sciences Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
USANA Health Sciences (USNA) Misses Q2 EPS by 17c; Lowers Outlook, $100M Buyback
July 25, 2017 4:19 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.98, $0.17 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $257.1 million versus the consensus estimate of $284.44 million.
GUIDANCE:
USANA Health Sciences sees FY2017 EPS of $3.50-$3.70, versus the... More
